Medical devices, healthcare technology and the business of care
510(k) clearance · K261085

Rapid Vessel Occlusion (Rapid VO)

iSchemaview · Decision date Jul 13, 2026

FDA DECISIONK261085

What did the FDA decide?

FDA records K261085 as a 510(k) premarket notification, with a decision dated Jul 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jul 13, 2026

FDA source record

Regulatory record facts

Identifier
K261085
Regulatory pathway
510(k) premarket notification
Applicant
iSchemaview
Product code
QAS
Decision code
SESE
Decision date
Jul 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Radiological Computer-Assisted Triage And Notification Software.

Applicant
iSchemaview
Product code
QAS
FDA device class
2

FDA decision timeline

  1. K261085 received

    Application receipt date recorded by FDA.

  2. K261085 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QAS

Product / regulatory recordCompanyPathwayDecision dateSource
Ever Fortune.Ai, Co., Ltd.510(k) clearanceOct 30, 2026FDA
Ischemaview, Inc.510(k) clearanceOct 9, 2026FDA
A2z Radiology Ai, Inc.510(k) clearanceSep 16, 2026FDA
GuideAI Health510(k) clearanceJun 18, 2026FDA
Aidoc Medical , Ltd.510(k) clearanceMay 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

iSchemaview

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Golden, CO

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records